Current Food and Drug Administration (FDA) approved cholinesterase inhibitors namely: donepezil25, rivastigmine,26 and galantamine27, help only in postponing the onset of the symptoms of AD and do not treat the underlying disease.28 Here, BCHE is linked to Alzheimer disease.